Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 14/20 | 0.39 |
| ▸ | PIM2 | Q9P1W9 | 14/20 | 0.39 |
| ▸ | PIM3 | Q86V86 | 6/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736389 | 0.97 | PIM1 (0.36) | PIM1PIM2PIM3LIMK1MEN1 | |
| SCHEMBL21736433 | 0.94 | TNKS (0.33) | PIM1PIM2PIM3LIMK1MEN1 | |
| SCHEMBL26743108 | 0.93 | LIMK1 (0.34) | PIM1PIM2PIM3LIMK1MEN1 | |
| SCHEMBL21736111 | 0.92 | MEN1 (0.33) | PIM1PIM2MEN1LMNAMAPT | |
| SCHEMBL21736153 | 0.91 | PIM1 (0.34) | PIM1PIM2PIM3LIMK1 | |
| SCHEMBL26743062 | 0.90 | LIMK1 (0.34) | PIM1PIM2PIM3LIMK1MEN1 | |
| SCHEMBL25899062 | 0.88 | LIMK1 (0.35) | PIM1PIM2PIM3LIMK1MEN1 | |
| SCHEMBL20669818 | 0.88 | PIM1 (0.41) | PIM1PIM2PIM3LIMK1MEN1 | |
| SCHEMBL21736167 | 0.87 | TNKS (0.33) | MAPK9MAPK14 | |
| SCHEMBL21736390 | 0.87 | TNKS (0.34) | MAPK9MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | PIM1 2216/4885PIM2 2772/4885PIM3 3873/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | PIM1 2216/4885PIM2 2772/4885PIM3 3873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.